According to the Decision Resources Group, there are many trends for the pharma industry in 2018. Amazon’s expected entry into the healthcare market will drive a surge of investment in digital innovation. Demand for digital tools will outstrip supply but create opportunities for pharmas to partner with tech companies on large-scale patient support solutions. Also, the use of real-world data in post-marketing approvals/new indications will accelerate with FDA’s encouragement, fueling demand for data expertise within pharma and further fusing the health tech and pharma worlds.